

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | omega-hydroxylase P450 pathway (GO:0097267) | 7.22834844 |
| 2 | exogenous drug catabolic process (GO:0042738) | 6.59074149 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 6.50015866 |
| 4 | complement activation, alternative pathway (GO:0006957) | 6.42294467 |
| 5 | drug catabolic process (GO:0042737) | 6.35948350 |
| 6 | regulation of protein activation cascade (GO:2000257) | 6.00581684 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.90019222 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 5.90019222 |
| 9 | regulation of fibrinolysis (GO:0051917) | 5.82099843 |
| 10 | regulation of complement activation (GO:0030449) | 5.82037685 |
| 11 | positive regulation of glycolytic process (GO:0045821) | 5.53644292 |
| 12 | protein carboxylation (GO:0018214) | 5.38135841 |
| 13 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.38135841 |
| 14 | fatty acid homeostasis (GO:0055089) | 5.32990852 |
| 15 | L-phenylalanine metabolic process (GO:0006558) | 5.22666006 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.22666006 |
| 17 | glyoxylate metabolic process (GO:0046487) | 5.06290420 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 4.95148158 |
| 19 | cellular ketone body metabolic process (GO:0046950) | 4.77972435 |
| 20 | negative regulation of gluconeogenesis (GO:0045721) | 4.74532948 |
| 21 | negative regulation of acute inflammatory response (GO:0002674) | 4.67597366 |
| 22 | ethanol oxidation (GO:0006069) | 4.64053680 |
| 23 | positive regulation of respiratory burst (GO:0060267) | 4.63533904 |
| 24 | oxidative demethylation (GO:0070989) | 4.63519777 |
| 25 | imidazole-containing compound metabolic process (GO:0052803) | 4.54108406 |
| 26 | blood coagulation, intrinsic pathway (GO:0007597) | 4.51651814 |
| 27 | regulation of glucokinase activity (GO:0033131) | 4.49066713 |
| 28 | regulation of hexokinase activity (GO:1903299) | 4.49066713 |
| 29 | endocrine pancreas development (GO:0031018) | 4.45638930 |
| 30 | phenylpropanoid metabolic process (GO:0009698) | 4.39685672 |
| 31 | aromatic amino acid family catabolic process (GO:0009074) | 4.38195057 |
| 32 | acute-phase response (GO:0006953) | 4.34772571 |
| 33 | drug metabolic process (GO:0017144) | 4.31637565 |
| 34 | fibrinolysis (GO:0042730) | 4.28956613 |
| 35 | ketone body metabolic process (GO:1902224) | 4.18610813 |
| 36 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.15879450 |
| 37 | protein activation cascade (GO:0072376) | 4.14299620 |
| 38 | urea metabolic process (GO:0019627) | 4.12166648 |
| 39 | serine family amino acid catabolic process (GO:0009071) | 4.04675532 |
| 40 | complement activation, classical pathway (GO:0006958) | 4.03435113 |
| 41 | nitric oxide mediated signal transduction (GO:0007263) | 4.01232220 |
| 42 | bile acid biosynthetic process (GO:0006699) | 4.00895240 |
| 43 | positive regulation of glycogen biosynthetic process (GO:0045725) | 3.98011238 |
| 44 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.95251250 |
| 45 | acylglycerol homeostasis (GO:0055090) | 3.94007291 |
| 46 | triglyceride homeostasis (GO:0070328) | 3.94007291 |
| 47 | complement activation (GO:0006956) | 3.89897667 |
| 48 | negative regulation of protein oligomerization (GO:0032460) | 3.88826647 |
| 49 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.81840431 |
| 50 | negative regulation of cholesterol transport (GO:0032375) | 3.81006448 |
| 51 | negative regulation of sterol transport (GO:0032372) | 3.81006448 |
| 52 | nitrogen cycle metabolic process (GO:0071941) | 3.76392919 |
| 53 | negative regulation of glycogen metabolic process (GO:0070874) | 3.72005414 |
| 54 | regulation of triglyceride catabolic process (GO:0010896) | 3.69652896 |
| 55 | negative regulation of protein activation cascade (GO:2000258) | 3.68459268 |
| 56 | regulation of plasminogen activation (GO:0010755) | 3.66889525 |
| 57 | opsonization (GO:0008228) | 3.65102175 |
| 58 | S-adenosylmethionine metabolic process (GO:0046500) | 3.61819368 |
| 59 | ethanol metabolic process (GO:0006067) | 3.61000940 |
| 60 | high-density lipoprotein particle remodeling (GO:0034375) | 3.60540598 |
| 61 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.58762081 |
| 62 | urea cycle (GO:0000050) | 3.49297844 |
| 63 | regulation of humoral immune response (GO:0002920) | 3.47270743 |
| 64 | positive regulation of glycogen metabolic process (GO:0070875) | 3.45813075 |
| 65 | glutamate metabolic process (GO:0006536) | 3.45106185 |
| 66 | exocrine pancreas development (GO:0031017) | 3.43217353 |
| 67 | cellular glucuronidation (GO:0052695) | 3.37342995 |
| 68 | positive regulation of peptide hormone secretion (GO:0090277) | 3.34619115 |
| 69 | protein-lipid complex remodeling (GO:0034368) | 3.34564419 |
| 70 | macromolecular complex remodeling (GO:0034367) | 3.34564419 |
| 71 | plasma lipoprotein particle remodeling (GO:0034369) | 3.34564419 |
| 72 | lactate metabolic process (GO:0006089) | 3.34021516 |
| 73 | bile acid metabolic process (GO:0008206) | 3.30712569 |
| 74 | negative regulation of hemostasis (GO:1900047) | 3.30667318 |
| 75 | negative regulation of blood coagulation (GO:0030195) | 3.30667318 |
| 76 | cholesterol efflux (GO:0033344) | 3.26244147 |
| 77 | uronic acid metabolic process (GO:0006063) | 3.24869779 |
| 78 | glucuronate metabolic process (GO:0019585) | 3.24869779 |
| 79 | regulation of acute inflammatory response (GO:0002673) | 3.23622567 |
| 80 | positive regulation of peptide secretion (GO:0002793) | 3.21177048 |
| 81 | reverse cholesterol transport (GO:0043691) | 3.19391632 |
| 82 | negative regulation of complement activation (GO:0045916) | 3.18526111 |
| 83 | xenobiotic catabolic process (GO:0042178) | 3.18069016 |
| 84 | tyrosine metabolic process (GO:0006570) | 3.14967182 |
| 85 | acute inflammatory response (GO:0002526) | 3.13954149 |
| 86 | negative regulation of wound healing (GO:0061045) | 3.09245966 |
| 87 | regulation of cholesterol esterification (GO:0010872) | 3.07106331 |
| 88 | alpha-amino acid catabolic process (GO:1901606) | 3.06612815 |
| 89 | negative regulation of coagulation (GO:0050819) | 3.06378217 |
| 90 | positive regulation of protein autophosphorylation (GO:0031954) | 3.05555896 |
| 91 | intestinal cholesterol absorption (GO:0030299) | 3.04584001 |
| 92 | indolalkylamine catabolic process (GO:0046218) | 3.03240243 |
| 93 | tryptophan catabolic process (GO:0006569) | 3.03240243 |
| 94 | indole-containing compound catabolic process (GO:0042436) | 3.03240243 |
| 95 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.01695394 |
| 96 | cytolysis (GO:0019835) | 2.99505578 |
| 97 | fructose metabolic process (GO:0006000) | 2.99284447 |
| 98 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.97942654 |
| 99 | regulation of glycolytic process (GO:0006110) | 2.96763793 |
| 100 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.95287906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.85610124 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.77104087 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.86392752 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.68758282 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.33610124 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.30816691 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.95932364 |
| 8 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.71364895 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.62016588 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.50702733 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.37352399 |
| 12 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.22199209 |
| 13 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.08649356 |
| 14 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.91803939 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.91537791 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.88368831 |
| 17 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.86641779 |
| 18 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.69317722 |
| 19 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.64621511 |
| 20 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.61147342 |
| 21 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.52995282 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.51709091 |
| 23 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.45473114 |
| 24 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.38527578 |
| 25 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.35628667 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.32694948 |
| 27 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.31136961 |
| 28 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.31008604 |
| 29 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.27988388 |
| 30 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.27224547 |
| 31 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27166493 |
| 32 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.24039292 |
| 33 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.21472910 |
| 34 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.20988917 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.18662012 |
| 36 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17794263 |
| 37 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.17661913 |
| 38 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.17312767 |
| 39 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.16547337 |
| 40 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.16212093 |
| 41 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.16212093 |
| 42 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.16204023 |
| 43 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.15775757 |
| 44 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.15434169 |
| 45 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.14676086 |
| 46 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.13978959 |
| 47 | STAT3_23295773_ChIP-Seq_U87_Human | 1.13704199 |
| 48 | AR_20517297_ChIP-Seq_VCAP_Human | 1.11964124 |
| 49 | CBP_21632823_ChIP-Seq_H3396_Human | 1.11562067 |
| 50 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09493825 |
| 51 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.09244014 |
| 52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.09143401 |
| 53 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08913796 |
| 54 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.08678869 |
| 55 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08546754 |
| 56 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.08199833 |
| 57 | P300_19829295_ChIP-Seq_ESCs_Human | 1.07903371 |
| 58 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07634826 |
| 59 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.07519302 |
| 60 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.06892273 |
| 61 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.06786373 |
| 62 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.05839562 |
| 63 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05198994 |
| 64 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04394320 |
| 65 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.04226409 |
| 66 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.04011268 |
| 67 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.02177946 |
| 68 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01569121 |
| 69 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.00949935 |
| 70 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.00873571 |
| 71 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00074325 |
| 72 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99988625 |
| 73 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.99769337 |
| 74 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99619549 |
| 75 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.99066355 |
| 76 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.98600472 |
| 77 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.98076046 |
| 78 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.97492889 |
| 79 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.97253731 |
| 80 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.96955107 |
| 81 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.96735638 |
| 82 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96714135 |
| 83 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96640572 |
| 84 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.95286501 |
| 85 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.94779189 |
| 86 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.94779189 |
| 87 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.94753552 |
| 88 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.94740561 |
| 89 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.94409701 |
| 90 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.94389267 |
| 91 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.94034714 |
| 92 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.93876381 |
| 93 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.93719053 |
| 94 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.93717369 |
| 95 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.93054224 |
| 96 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92318435 |
| 97 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92287905 |
| 98 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.91314760 |
| 99 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.91247035 |
| 100 | VDR_22108803_ChIP-Seq_LS180_Human | 0.90966761 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003195_calcinosis | 7.78463349 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.97734133 |
| 3 | MP0005365_abnormal_bile_salt | 3.92291336 |
| 4 | MP0003283_abnormal_digestive_organ | 3.82816116 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.64167626 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.44620386 |
| 7 | MP0005360_urolithiasis | 3.17928615 |
| 8 | MP0003252_abnormal_bile_duct | 2.97415493 |
| 9 | MP0002909_abnormal_adrenal_gland | 2.96617176 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 2.88255307 |
| 11 | MP0003122_maternal_imprinting | 2.76474509 |
| 12 | MP0003787_abnormal_imprinting | 2.53454127 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.51642772 |
| 14 | MP0003123_paternal_imprinting | 2.32949121 |
| 15 | MP0010234_abnormal_vibrissa_follicle | 2.29004467 |
| 16 | MP0005332_abnormal_amino_acid | 2.24332630 |
| 17 | MP0003868_abnormal_feces_composition | 2.13647953 |
| 18 | MP0001944_abnormal_pancreas_morphology | 2.09296448 |
| 19 | MP0002876_abnormal_thyroid_physiology | 2.06388480 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.05074641 |
| 21 | MP0009780_abnormal_chondrocyte_physiolo | 1.98823985 |
| 22 | MP0005379_endocrine/exocrine_gland_phen | 1.88132038 |
| 23 | MP0002693_abnormal_pancreas_physiology | 1.81802431 |
| 24 | MP0005220_abnormal_exocrine_pancreas | 1.80063637 |
| 25 | MP0001661_extended_life_span | 1.77321125 |
| 26 | MP0002837_dystrophic_cardiac_calcinosis | 1.66948427 |
| 27 | MP0002928_abnormal_bile_duct | 1.64525221 |
| 28 | MP0002118_abnormal_lipid_homeostasis | 1.64371549 |
| 29 | MP0002078_abnormal_glucose_homeostasis | 1.62114617 |
| 30 | MP0000013_abnormal_adipose_tissue | 1.59338846 |
| 31 | MP0009840_abnormal_foam_cell | 1.58458534 |
| 32 | MP0002163_abnormal_gland_morphology | 1.55760561 |
| 33 | MP0010368_abnormal_lymphatic_system | 1.45829597 |
| 34 | MP0009697_abnormal_copulation | 1.32323247 |
| 35 | MP0000609_abnormal_liver_physiology | 1.31736229 |
| 36 | MP0002638_abnormal_pupillary_reflex | 1.29743495 |
| 37 | MP0009643_abnormal_urine_homeostasis | 1.23686149 |
| 38 | MP0005645_abnormal_hypothalamus_physiol | 1.20449044 |
| 39 | MP0004510_myositis | 1.18592041 |
| 40 | MP0004019_abnormal_vitamin_homeostasis | 1.18498483 |
| 41 | MP0005448_abnormal_energy_balance | 1.15535060 |
| 42 | MP0002822_catalepsy | 1.14053757 |
| 43 | MP0000462_abnormal_digestive_system | 1.12424264 |
| 44 | MP0003011_delayed_dark_adaptation | 1.12093617 |
| 45 | MP0005636_abnormal_mineral_homeostasis | 1.11192948 |
| 46 | MP0002168_other_aberrant_phenotype | 1.08994525 |
| 47 | MP0001756_abnormal_urination | 1.07454173 |
| 48 | MP0000003_abnormal_adipose_tissue | 1.03651890 |
| 49 | MP0008872_abnormal_physiological_respon | 0.98057550 |
| 50 | MP0003121_genomic_imprinting | 0.98011224 |
| 51 | MP0008877_abnormal_DNA_methylation | 0.96503137 |
| 52 | MP0002971_abnormal_brown_adipose | 0.95169279 |
| 53 | MP0010386_abnormal_urinary_bladder | 0.94970596 |
| 54 | MP0003879_abnormal_hair_cell | 0.94769591 |
| 55 | MP0005535_abnormal_body_temperature | 0.93908856 |
| 56 | MP0001986_abnormal_taste_sensitivity | 0.93711253 |
| 57 | MP0003172_abnormal_lysosome_physiology | 0.93282332 |
| 58 | MP0001764_abnormal_homeostasis | 0.93161469 |
| 59 | MP0005319_abnormal_enzyme/_coenzyme | 0.93053746 |
| 60 | MP0003953_abnormal_hormone_level | 0.90488441 |
| 61 | MP0000639_abnormal_adrenal_gland | 0.90423859 |
| 62 | MP0005167_abnormal_blood-brain_barrier | 0.89040579 |
| 63 | MP0009642_abnormal_blood_homeostasis | 0.87426643 |
| 64 | MP0001984_abnormal_olfaction | 0.86579731 |
| 65 | MP0003075_altered_response_to | 0.86540492 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 0.85612713 |
| 67 | MP0005646_abnormal_pituitary_gland | 0.85163668 |
| 68 | MP0003045_fibrosis | 0.82715537 |
| 69 | MP0003690_abnormal_glial_cell | 0.82253632 |
| 70 | MP0003633_abnormal_nervous_system | 0.80476990 |
| 71 | MP0002295_abnormal_pulmonary_circulatio | 0.80439695 |
| 72 | MP0003191_abnormal_cellular_cholesterol | 0.80303089 |
| 73 | MP0002102_abnormal_ear_morphology | 0.79332286 |
| 74 | MP0000598_abnormal_liver_morphology | 0.76044047 |
| 75 | MP0009046_muscle_twitch | 0.75306179 |
| 76 | MP0002090_abnormal_vision | 0.75219735 |
| 77 | MP0004133_heterotaxia | 0.74622792 |
| 78 | MP0000678_abnormal_parathyroid_gland | 0.73520276 |
| 79 | MP0005395_other_phenotype | 0.72560239 |
| 80 | MP0005266_abnormal_metabolism | 0.65441499 |
| 81 | MP0010678_abnormal_skin_adnexa | 0.63311477 |
| 82 | MP0004043_abnormal_pH_regulation | 0.62300107 |
| 83 | MP0005376_homeostasis/metabolism_phenot | 0.58354937 |
| 84 | MP0005084_abnormal_gallbladder_morpholo | 0.57479673 |
| 85 | MP0005551_abnormal_eye_electrophysiolog | 0.56872422 |
| 86 | MP0008775_abnormal_heart_ventricle | 0.55321349 |
| 87 | MP0003943_abnormal_hepatobiliary_system | 0.55106300 |
| 88 | MP0005670_abnormal_white_adipose | 0.53346147 |
| 89 | MP0006036_abnormal_mitochondrial_physio | 0.52366775 |
| 90 | MP0006072_abnormal_retinal_apoptosis | 0.51771206 |
| 91 | MP0002108_abnormal_muscle_morphology | 0.50896688 |
| 92 | MP0001765_abnormal_ion_homeostasis | 0.49418243 |
| 93 | MP0000230_abnormal_systemic_arterial | 0.49173933 |
| 94 | MP0001440_abnormal_grooming_behavior | 0.47480619 |
| 95 | MP0005367_renal/urinary_system_phenotyp | 0.47146628 |
| 96 | MP0000516_abnormal_urinary_system | 0.47146628 |
| 97 | MP0005334_abnormal_fat_pad | 0.46463521 |
| 98 | MP0001727_abnormal_embryo_implantation | 0.46426240 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.46078220 |
| 100 | MP0002132_abnormal_respiratory_system | 0.45752679 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic seizures (HP:0002173) | 7.93606892 |
| 2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 6.99619307 |
| 3 | Hypoglycemic coma (HP:0001325) | 6.74241669 |
| 4 | Complement deficiency (HP:0004431) | 6.51799927 |
| 5 | Ketoacidosis (HP:0001993) | 6.18942156 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.00411326 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.86795535 |
| 8 | Abnormality of the pancreatic islet cells (HP:0006476) | 5.66657708 |
| 9 | Abnormality of endocrine pancreas physiology (HP:0012093) | 5.66657708 |
| 10 | Hyperglycemia (HP:0003074) | 5.41813971 |
| 11 | Deep venous thrombosis (HP:0002625) | 5.18081297 |
| 12 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.14077163 |
| 13 | Hypobetalipoproteinemia (HP:0003563) | 5.12494438 |
| 14 | Symptomatic seizures (HP:0011145) | 5.11386359 |
| 15 | Abnormality of complement system (HP:0005339) | 4.87061907 |
| 16 | Joint hemorrhage (HP:0005261) | 4.59035497 |
| 17 | Ketosis (HP:0001946) | 4.53528869 |
| 18 | Late onset (HP:0003584) | 4.33252794 |
| 19 | Hyperlipoproteinemia (HP:0010980) | 4.13007275 |
| 20 | Systemic lupus erythematosus (HP:0002725) | 4.10207268 |
| 21 | Glomerulonephritis (HP:0000099) | 3.96349623 |
| 22 | Conjugated hyperbilirubinemia (HP:0002908) | 3.80059106 |
| 23 | Large for gestational age (HP:0001520) | 3.71028753 |
| 24 | Xanthomatosis (HP:0000991) | 3.69196163 |
| 25 | Prominent metopic ridge (HP:0005487) | 3.67946837 |
| 26 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.55193734 |
| 27 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.53010981 |
| 28 | EEG with generalized epileptiform discharges (HP:0011198) | 3.28777098 |
| 29 | Hypothermia (HP:0002045) | 3.27441549 |
| 30 | Epileptiform EEG discharges (HP:0011182) | 3.24173355 |
| 31 | Abnormality of the metopic suture (HP:0005556) | 3.22688801 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.20982482 |
| 33 | Hypsarrhythmia (HP:0002521) | 3.20168188 |
| 34 | Intrahepatic cholestasis (HP:0001406) | 3.12483737 |
| 35 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.94487074 |
| 36 | Abnormality of methionine metabolism (HP:0010901) | 2.90339775 |
| 37 | Hypolipoproteinemia (HP:0010981) | 2.86022011 |
| 38 | Type I diabetes mellitus (HP:0100651) | 2.79915171 |
| 39 | Hypomagnesemia (HP:0002917) | 2.74532710 |
| 40 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.59640837 |
| 41 | Neonatal hypoglycemia (HP:0001998) | 2.59158427 |
| 42 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.54314325 |
| 43 | Nephritis (HP:0000123) | 2.48084095 |
| 44 | Increased circulating renin level (HP:0000848) | 2.47878132 |
| 45 | Asymmetry of the thorax (HP:0001555) | 2.47721013 |
| 46 | Abnormal pancreas size (HP:0012094) | 2.42585493 |
| 47 | Mitral stenosis (HP:0001718) | 2.41254826 |
| 48 | Fair hair (HP:0002286) | 2.40487403 |
| 49 | Enlarged penis (HP:0000040) | 2.40268418 |
| 50 | Insulin resistance (HP:0000855) | 2.34193894 |
| 51 | Fat malabsorption (HP:0002630) | 2.31973154 |
| 52 | Abnormality of the common coagulation pathway (HP:0010990) | 2.30838404 |
| 53 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.25967751 |
| 54 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.24293912 |
| 55 | Hypoalphalipoproteinemia (HP:0003233) | 2.17382764 |
| 56 | Abnormality of magnesium homeostasis (HP:0004921) | 2.08419700 |
| 57 | Hyperphosphaturia (HP:0003109) | 2.07010284 |
| 58 | Spontaneous abortion (HP:0005268) | 2.06523246 |
| 59 | Vascular calcification (HP:0004934) | 2.05936866 |
| 60 | Steatorrhea (HP:0002570) | 2.01957811 |
| 61 | Hyperphosphatemia (HP:0002905) | 2.00272962 |
| 62 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.99659528 |
| 63 | Enlarged kidneys (HP:0000105) | 1.96699336 |
| 64 | Lymphangioma (HP:0100764) | 1.93799081 |
| 65 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.87430309 |
| 66 | Neoplasm of the adrenal cortex (HP:0100641) | 1.86268383 |
| 67 | Hypokinesia (HP:0002375) | 1.82747814 |
| 68 | Hepatoblastoma (HP:0002884) | 1.82339563 |
| 69 | Abnormality of vitamin metabolism (HP:0100508) | 1.80399869 |
| 70 | Cardiovascular calcification (HP:0011915) | 1.79760338 |
| 71 | Epidermoid cyst (HP:0200040) | 1.78349689 |
| 72 | Generalized aminoaciduria (HP:0002909) | 1.77402694 |
| 73 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.76755804 |
| 74 | Downturned corners of mouth (HP:0002714) | 1.76528447 |
| 75 | Hyperthyroidism (HP:0000836) | 1.73858781 |
| 76 | Abnormality of urine glucose concentration (HP:0011016) | 1.73000766 |
| 77 | Glycosuria (HP:0003076) | 1.73000766 |
| 78 | Delayed CNS myelination (HP:0002188) | 1.72472878 |
| 79 | Muscular hypotonia of the trunk (HP:0008936) | 1.71988002 |
| 80 | Hypercholesterolemia (HP:0003124) | 1.71806566 |
| 81 | Blue irides (HP:0000635) | 1.71632434 |
| 82 | Hyperglycinemia (HP:0002154) | 1.69542538 |
| 83 | Hematochezia (HP:0002573) | 1.69254214 |
| 84 | Hydroxyprolinuria (HP:0003080) | 1.69247149 |
| 85 | Abnormality of proline metabolism (HP:0010907) | 1.69247149 |
| 86 | Hepatic necrosis (HP:0002605) | 1.68653875 |
| 87 | Lower limb hyperreflexia (HP:0002395) | 1.66763748 |
| 88 | Metaphyseal dysplasia (HP:0100255) | 1.64848470 |
| 89 | Gout (HP:0001997) | 1.64031254 |
| 90 | Megaloblastic anemia (HP:0001889) | 1.63435645 |
| 91 | Polydipsia (HP:0001959) | 1.62399745 |
| 92 | Abnormal drinking behavior (HP:0030082) | 1.62399745 |
| 93 | Conjunctival hamartoma (HP:0100780) | 1.60909851 |
| 94 | Generalized hypopigmentation of hair (HP:0011358) | 1.59658191 |
| 95 | Hamartoma of the eye (HP:0010568) | 1.59149978 |
| 96 | Gingival bleeding (HP:0000225) | 1.55441693 |
| 97 | Hyperammonemia (HP:0001987) | 1.54652512 |
| 98 | Abnormal urine phosphate concentration (HP:0012599) | 1.53062054 |
| 99 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.52187273 |
| 100 | Abnormality of glycine metabolism (HP:0010895) | 1.52187273 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 8.11226025 |
| 2 | PASK | 4.84218574 |
| 3 | FGFR2 | 4.68178979 |
| 4 | NTRK3 | 2.75166021 |
| 5 | MAP3K2 | 2.73576578 |
| 6 | TIE1 | 2.62209417 |
| 7 | FGFR3 | 2.62203987 |
| 8 | DAPK2 | 2.35038803 |
| 9 | NLK | 2.16061863 |
| 10 | BMPR1B | 1.88750927 |
| 11 | PRKAA2 | 1.82556027 |
| 12 | FGFR4 | 1.81414504 |
| 13 | HIPK2 | 1.79491466 |
| 14 | PHKG2 | 1.75746890 |
| 15 | PHKG1 | 1.75746890 |
| 16 | FER | 1.64871250 |
| 17 | EPHA3 | 1.54432909 |
| 18 | GRK1 | 1.48591702 |
| 19 | TRPM7 | 1.43559576 |
| 20 | INSRR | 1.37046236 |
| 21 | ADRBK2 | 1.34933309 |
| 22 | PRKAA1 | 1.28500158 |
| 23 | MAP3K1 | 1.28285532 |
| 24 | PTK2B | 1.21601625 |
| 25 | ERN1 | 1.18304618 |
| 26 | MAP4K2 | 1.14778442 |
| 27 | PRKCG | 1.07150144 |
| 28 | AKT3 | 1.05356208 |
| 29 | MAP2K6 | 1.04702253 |
| 30 | STK39 | 1.00942089 |
| 31 | IRAK1 | 1.00803705 |
| 32 | PAK3 | 0.97569189 |
| 33 | KIT | 0.87258415 |
| 34 | TNIK | 0.86873440 |
| 35 | CSNK1G1 | 0.86819075 |
| 36 | SGK2 | 0.86435240 |
| 37 | MAP3K7 | 0.86393010 |
| 38 | STK11 | 0.83979248 |
| 39 | MAPK11 | 0.81721654 |
| 40 | SGK223 | 0.80006921 |
| 41 | SGK494 | 0.80006921 |
| 42 | STK38L | 0.79607160 |
| 43 | WNK4 | 0.76691193 |
| 44 | LIMK1 | 0.76354827 |
| 45 | NUAK1 | 0.72880248 |
| 46 | ACVR1B | 0.72190977 |
| 47 | KDR | 0.67448748 |
| 48 | PRKCE | 0.63333731 |
| 49 | TAOK3 | 0.61482307 |
| 50 | WNK3 | 0.60761424 |
| 51 | CAMK2D | 0.60191344 |
| 52 | PTK2 | 0.59596901 |
| 53 | TYK2 | 0.59522798 |
| 54 | PIK3CG | 0.59415021 |
| 55 | MAP3K4 | 0.59327451 |
| 56 | PINK1 | 0.58683859 |
| 57 | PRKACG | 0.58402351 |
| 58 | ABL2 | 0.57989485 |
| 59 | OXSR1 | 0.56362682 |
| 60 | JAK1 | 0.56194722 |
| 61 | ADRBK1 | 0.54415249 |
| 62 | STK3 | 0.53488213 |
| 63 | EPHB1 | 0.53037125 |
| 64 | PRKACA | 0.52835376 |
| 65 | SGK3 | 0.51470188 |
| 66 | PRKCZ | 0.50991542 |
| 67 | LMTK2 | 0.50823096 |
| 68 | CASK | 0.49877098 |
| 69 | BCKDK | 0.49223036 |
| 70 | CAMK1G | 0.47661269 |
| 71 | PRKG1 | 0.45403994 |
| 72 | CSNK1G3 | 0.45049643 |
| 73 | SGK1 | 0.44320891 |
| 74 | GSK3A | 0.41683659 |
| 75 | PRKCA | 0.39507424 |
| 76 | CDK3 | 0.38050621 |
| 77 | PLK2 | 0.37078573 |
| 78 | MAP2K4 | 0.36020673 |
| 79 | TAOK1 | 0.35386745 |
| 80 | CSNK1G2 | 0.34829673 |
| 81 | STK38 | 0.33769836 |
| 82 | PNCK | 0.33621330 |
| 83 | OBSCN | 0.33514799 |
| 84 | CSNK1D | 0.29694896 |
| 85 | ROCK1 | 0.29046882 |
| 86 | TRIM28 | 0.28521562 |
| 87 | MAPK7 | 0.28042930 |
| 88 | PIK3CA | 0.26834844 |
| 89 | PRKG2 | 0.26467493 |
| 90 | CHUK | 0.25899715 |
| 91 | PRKACB | 0.25862479 |
| 92 | IGF1R | 0.25452775 |
| 93 | RPS6KA3 | 0.24704737 |
| 94 | PDGFRA | 0.22079002 |
| 95 | TEC | 0.21791474 |
| 96 | PDGFRB | 0.21698887 |
| 97 | MAP2K7 | 0.21107798 |
| 98 | DAPK1 | 0.21081533 |
| 99 | MAPK1 | 0.20891113 |
| 100 | CSNK1A1 | 0.20534056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.02014751 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.51832652 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.22056576 |
| 4 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.09470520 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.00050206 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.90614459 |
| 7 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.61258719 |
| 8 | Retinol metabolism_Homo sapiens_hsa00830 | 2.60853697 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.48993879 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48252330 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.15614143 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.11811383 |
| 13 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.10992096 |
| 14 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.06351318 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.05842786 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.86751454 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.80388606 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.77725041 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.74160903 |
| 20 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.73246010 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.73105380 |
| 22 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.72262245 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.68358074 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.63421264 |
| 25 | Insulin secretion_Homo sapiens_hsa04911 | 1.62078767 |
| 26 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.56832778 |
| 27 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52173364 |
| 28 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.50773944 |
| 29 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.50025666 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.45184036 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.37424275 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.28336759 |
| 33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27633407 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.27120169 |
| 35 | ABC transporters_Homo sapiens_hsa02010 | 1.25926001 |
| 36 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.18246094 |
| 37 | Protein export_Homo sapiens_hsa03060 | 1.14411261 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.10959628 |
| 39 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.08054849 |
| 40 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.01147707 |
| 41 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.99953863 |
| 42 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.98671214 |
| 43 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98518160 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.97709379 |
| 45 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.94422494 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.91741490 |
| 47 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.90819358 |
| 48 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.90580782 |
| 49 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.87928644 |
| 50 | Prion diseases_Homo sapiens_hsa05020 | 0.82038019 |
| 51 | Insulin resistance_Homo sapiens_hsa04931 | 0.77042910 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.68076514 |
| 53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67869302 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66827579 |
| 55 | Lysine degradation_Homo sapiens_hsa00310 | 0.65803981 |
| 56 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.63525222 |
| 57 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62253466 |
| 58 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59933727 |
| 59 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.57799164 |
| 60 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57558560 |
| 61 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.57349560 |
| 62 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.57225891 |
| 63 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.54786414 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53229905 |
| 65 | Circadian rhythm_Homo sapiens_hsa04710 | 0.51959922 |
| 66 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51909048 |
| 67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51063735 |
| 68 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49313004 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 0.48264888 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43371591 |
| 71 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.42473462 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36706058 |
| 73 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.36413322 |
| 74 | Renin secretion_Homo sapiens_hsa04924 | 0.35393104 |
| 75 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.33341653 |
| 76 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.32861575 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30853543 |
| 78 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.29601827 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29057365 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.27954951 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27789601 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.22947784 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.22381076 |
| 84 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.21650844 |
| 85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.21443445 |
| 86 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.21230678 |
| 87 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.19457406 |
| 88 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.19407937 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.15666398 |
| 90 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.15582177 |
| 91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.15159477 |
| 92 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.14542809 |
| 93 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.12940762 |
| 94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.12328925 |
| 95 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.12008080 |
| 96 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.10857332 |
| 97 | Pertussis_Homo sapiens_hsa05133 | 0.10794799 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.09346312 |
| 99 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.08948632 |
| 100 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.07004062 |

